NYSEMKT: SER
Serina Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for SER

Based on 2 analysts offering 12 month price targets for Serina Therapeutics Inc

Min Forecast
$11.00+110.53%
Avg Forecast
$13.00+148.8%
Max Forecast
$15.00+187.08%

Should I buy or sell SER stock?

Based on 2 analysts offering ratings for Serina Therapeutics Inc.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SER stock forecasts and price targets.

SER stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-07-14
lockedlocked$00.00+00.00%2025-03-11

1 of 1

SER vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SER$5.23$13.00+148.80%Strong Buy
PRLD$0.94$4.00+323.73%Buy
ATNM$1.71$4.00+133.92%Buy
PSTV$0.54$8.88+1,555.78%Buy
ALGS$8.77$60.00+584.15%Buy

Serina Therapeutics Stock Forecast FAQ

Is Serina Therapeutics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NYSEMKT: SER) stock is to Strong Buy SER stock.

Out of 2 analysts, 1 (50%) are recommending SER as a Strong Buy, 1 (50%) are recommending SER as a Buy, 0 (0%) are recommending SER as a Hold, 0 (0%) are recommending SER as a Sell, and 0 (0%) are recommending SER as a Strong Sell.

If you're new to stock investing, here's how to buy Serina Therapeutics stock.

What is SER's Price Target?

According to 2 Wall Street analysts that have issued a 1 year SER price target, the average SER price target is $13.00, with the highest SER stock price forecast at $15.00 and the lowest SER stock price forecast at $11.00.

On average, Wall Street analysts predict that Serina Therapeutics's share price could reach $13.00 by Jul 14, 2026. The average Serina Therapeutics stock price prediction forecasts a potential upside of 148.8% from the current SER share price of $5.23.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.